Pulse nav.journalClub Debates ativos Tendências Explorar Pesquisadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Início Explorar nav.journalClub Tendências

⌘+K

© Synapse Social LLC, 2026

Política de privacidade

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF | Synapse

April 21, 2016Open Access

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF

Key Points

Key points are not available for this paper at this time.

Abstract

NCT01725139, pre-clinical.

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Perguntar à IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Mercer et al. (Thu,) studied this question.

synapsesocial.com/papers/69dbd4c7f7e0c66ced8366bc https://doi.org/https://doi.org/10.1136/thoraxjnl-2015-207429

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Does interstitial lung disease predispose to lung cancer?2005 · 145 citations
2Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin2010 · 373 citations
3The emerging mechanisms of isoform-specific PI3K signalling2010 · 1,732 citations
4A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL182006 · 504 citations
5Surface modification of a POSS-nanocomposite material to enhance cellular integration of a synthetic bioscaffold2016 · 62 citations